List of Excipients in API BEPOTASTINE BESILATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BEPOTASTINE BESILATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | BEPREVE | bepotastine besilate | 24208-629 | BENZALKONIUM CHLORIDE | |
| Bausch & Lomb Incorporated | BEPREVE | bepotastine besilate | 24208-629 | SODIUM CHLORIDE | |
| Bausch & Lomb Incorporated | BEPREVE | bepotastine besilate | 24208-629 | SODIUM HYDROXIDE | |
| Bausch & Lomb Incorporated | BEPREVE | bepotastine besilate | 24208-629 | SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | |
| Bausch & Lomb Incorporated | BEPREVE | bepotastine besilate | 24208-629 | WATER | |
| Bausch & Lomb Incorporated | BEPOTASTINE BESILATE | bepotastine besilate | 24208-630 | BENZALKONIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BEPOTASTINE BESILATE
Detailed excipient profiles for BEPOTASTINE BESILATE
Excipient focus: BENZALKONIUM CHLORIDE
BEPOTASTINE BESILATE drug variants containing BENZALKONIUM CHLORIDE
BEPOTASTINE BESILATE drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
BEPOTASTINE BESILATE drug variants containing SODIUM CHLORIDE
BEPOTASTINE BESILATE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
BEPOTASTINE BESILATE drug variants containing SODIUM HYDROXIDE
BEPOTASTINE BESILATE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
BEPOTASTINE BESILATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
BEPOTASTINE BESILATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
BEPOTASTINE BESILATE drug variants containing WATER
BEPOTASTINE BESILATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
